The United Kingdom administers the first doses of Pfizer's coronavirus disease 2019 (COVID-19) vaccine; an FDA review confirms the safety and efficacy of Pfizer's vaccine; Fauci advises holiday gatherings be limited to 10 or less people.
The first patients in the United Kingdom have received a Pfizer/BioNTech coronavirus disease 2019 (COVID-19) immunization as part of a new mass vaccination program, BBC News reports. Margaret Keenan, who turns 91 next week, received the first of 800,000 doses to be dispensed in the coming weeks. Vaccination hubs throughout the United Kingdom expect to vaccinate citizens 80 years and older and some health care staff soon, as up to 4 million more doses are expected to be administered by the end of the month. The United Kingdom is the first country in the world to begin distributing the vaccine, which was approved there last week.
A 53-page review published by the FDA confirmed that Pfizer and BioNTech’s COVID-19 vaccine meets the standard for emergency use authorization (EUA) in the United States. Reported by The Washington Post, the briefing document is the most detailed independent review yet of the data and confirms that the 2-shot regimen is 95% effective. Short-term adverse effects include sore arms, fatigue, headaches, muscle pain, and chills, which all typically resolve in 1 to 2 days. The review also concluded the vaccine can begin to protect individuals even after the first dose. An FDA advisory panel is slated to hear Pfizer’s application for its vaccine candidate this Thursday.
Anthony Fauci, MD, the nation’s top infectious disease expert, said Americans should limit holiday gatherings to 10 individuals or fewer to help stem the spread of COVID-19 surging across the nation, NPR reports. Fauci made the remarks during a COVID-19 briefing held by New York Governor Andrew Cuomo. Warning that holiday gatherings could emerge as major vectors of the disease, Fauci said he expects coronavirus cases to continue to rise nationwide into January. According to the Johns Hopkins Coronavirus Resource Center, the United States has reported just under 15 million cases of COVID-19 and around 284,000 deaths.
AI Meets Medicare: Inside CMS’s WISeR Model With Sanjay Doddamani, MD, MBA, Part 2
August 5th 2025In this second part of his interview with The American Journal of Managed Care®, Sanjay Doddamani, MD, MBA, a former senior advisor to CMMI and founder and CEO of Guidehealth, continues a dialogue on the future of value-based care and the promise—and limits—of AI-enabled innovation, reflecting on challenges like rising Medicare costs and patients’ growing financial burdens.
Read More
Trump Directs Pharma Companies on Cutting Drug Prices Under Most-Favored-Nation Order
July 31st 2025President Donald Trump has sent letters to pharmaceutical companies, aiming to compel them to lower drug prices in the US to match the lowest prices offered in other developed nations, a move that could significantly reduce costs and disrupt the current system of pharmacy benefit managers.
Read More